Corresponding Author: Ajay Malhotra, MD, MMM, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, 333 Cedar St, PO Box 208042, Tompkins East 2, New Haven, CT 06520-8042 (ajay.malhotra@yale.edu).
Published Online: June 6, 2019. doi:10.1001/jamaophthalmol.2019.1053
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank Ying-Chun Lo, MD, Yale New Haven Hospital, for providing pathology consultation on this case. He was not compensated for his contributions. We thank the patient for granting permission to publish this information.
2.Cavalli
G, Guglielmi
B, Berti
A, Campochiaro
C, Sabbadini
MG, Dagna
L. The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases.
Ann Rheum Dis. 2013;72(10):1691-1695. doi:
10.1136/annrheumdis-2012-202542PubMedGoogle ScholarCrossref 8.Haroche
J, Cohen-Aubart
F, Emile
JF,
et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
Blood. 2013;121(9):1495-1500. doi:
10.1182/blood-2012-07-446286PubMedGoogle ScholarCrossref